Aki Yoshida

CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment

Tomohiro Fujiwara, Mohamed A. Yakoub, Andrew Chandler et al. · Molecular Cancer Therapeutics · 2021 · 258 citations · Full text

Medicine, Oncology, Pharmacology +17

Histone deacetylase inhibitor suppression of autoantibody‐mediated arthritis in mice via regulation of p16^INK4a and p21^WAF1/Cip1 expression

Keiichiro Nishida, Takamitsu Komiyama, Shin‐Ichi Miyazawa et al. · Arthritis & Rheumatism · 2004 · 216 citations

Medicine, Immunology, Pharmacology +13

Accurate diagnosis of musculoskeletal lesions by core needle biopsy

Goro Mitsuyoshi, Noriko Naito, Akira Kawai et al. · Journal of Surgical Oncology · 2006 · 162 citations

Medicine, Oncology, Pathology +17

Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells

Tomonori Tetsunaga, Keiichiro Nishida, Takayuki Furumatsu et al. · Osteoarthritis and Cartilage · 2010 · 150 citations

Life Sciences, Cell Biology, Molecular Biology +14

Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model

Y. Nasu, Keiichiro Nishida, Shinichi Miyazawa et al. · Osteoarthritis and Cartilage · 2008 · 147 citations · Full text

Medicine, Immunology, Pathology +17